Production (Stage)
Emmaus Life Sciences, Inc.
EMMA
$0.017
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.30% | -195.68% | 183.65% | 49.77% | -459.64% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -16.67% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 30.26% | 10.14% | 0.00% | -86.03% | -31.29% |
| Total Other Non-Cash Items | 122.82% | 63.31% | -200.26% | 4,120.83% | 97.18% |
| Change in Net Operating Assets | -13.86% | 1,394.51% | 106.65% | -167.84% | 401.37% |
| Cash from Operations | -18.66% | 131.76% | 105.07% | -2,183.57% | -86.49% |
| Capital Expenditure | -- | -700.00% | 133.33% | 25.00% | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | -- | -300.00% | -99.96% | 62,725.00% | 33.33% |
| Total Debt Issued | 32.53% | 13.75% | -20.08% | -28.50% | -31.51% |
| Total Debt Repaid | -40.36% | 10.74% | -61.62% | 67.47% | -14.93% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.92% | 55.48% | -286.38% | 124.61% | -19,000.00% |
| Foreign Exchange rate Adjustments | 183.33% | -163.16% | 290.00% | 37.50% | -194.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.79% | 149.63% | -44.39% | 77.60% | -180.13% |